Journal of Clinical Oncology

Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer

J Jennifer J. Knox G Grainne O'Kane (PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, ON, Canada) D Daniel King D Daniel Laheru A Amber N. Habowski (Lustgarten Foundation Pancreatic Cancer Research Laboratory, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) K Kenneth Yu (Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY) K Kimberly Perez (Dana Farber Cancer Institute and Harvard Medical School, Boston, MA) A Andrew J. Aguirre Z Zachary Coyne (Beaumont Hospital, Dublin 9, Ireland) H Harry Harvey (McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada) R Ronan A. McLaughlin (McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada) R Raymond W. Jang (McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada) R Robert C. Grant E Elena C. Elimova (McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada) D Daniel J. Renouf S Sandra Fischer (Laboratory Medicine Program, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada) K Kai Duan S Stephanie Ramotar G Gun Ho Jang A Amy Zhang C Craig E. Devoe (Northwell Heath, New York, NY) H Harshabad Singh M Michael J. Pishvaian F Fieke E.M. Froeling (Lustgarten Foundation Pancreatic Cancer Research Laboratory, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) M Muhammad W. Saif (Northwell Health Cancer Institute, Lake Success, NY) E Eileen M. O'Reilly (Memorial Sloan Kettering Cancer Center, New York City, NY) E Erica S. Tsang B Brian M. Wolpin J Julie M. Wilson A Anna Dodd T Trevor J. Pugh (Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto) X Xiang Y. Ye (Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada) S Steven Gallinger D David A. Tuveson F Faiyaz Notta E Elizabeth M. Jaffee
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 30
Published October 20, 2025
Pages 3325-3325
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (36)

J

Jennifer J. Knox

G

Grainne O'Kane

PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, ON, Canada

D

Daniel King

D

Daniel Laheru

A

Amber N. Habowski

Lustgarten Foundation Pancreatic Cancer Research Laboratory, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY

K

Kenneth Yu

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY

K

Kimberly Perez

Dana Farber Cancer Institute and Harvard Medical School, Boston, MA

A

Andrew J. Aguirre

Z

Zachary Coyne

Beaumont Hospital, Dublin 9, Ireland

H

Harry Harvey

McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

R

Ronan A. McLaughlin

McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

R

Raymond W. Jang

McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

R

Robert C. Grant

E

Elena C. Elimova

McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

D

Daniel J. Renouf

S

Sandra Fischer

Laboratory Medicine Program, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada

K

Kai Duan

S

Stephanie Ramotar

G

Gun Ho Jang

A

Amy Zhang

C

Craig E. Devoe

Northwell Heath, New York, NY

H

Harshabad Singh

M

Michael J. Pishvaian

F

Fieke E.M. Froeling

Lustgarten Foundation Pancreatic Cancer Research Laboratory, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY

M

Muhammad W. Saif

Northwell Health Cancer Institute, Lake Success, NY

E

Eileen M. O'Reilly

Memorial Sloan Kettering Cancer Center, New York City, NY

E

Erica S. Tsang

B

Brian M. Wolpin

J

Julie M. Wilson

A

Anna Dodd

T

Trevor J. Pugh

Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto

X

Xiang Y. Ye

Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada

S

Steven Gallinger

D

David A. Tuveson

F

Faiyaz Notta

E

Elizabeth M. Jaffee

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001